| Product Code: ETC12011421 | Publication Date: Apr 2025 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Nigeria Drug Repurposing Market Overview |
3.1 Nigeria Country Macro Economic Indicators |
3.2 Nigeria Drug Repurposing Market Revenues & Volume, 2021 & 2031F |
3.3 Nigeria Drug Repurposing Market - Industry Life Cycle |
3.4 Nigeria Drug Repurposing Market - Porter's Five Forces |
3.5 Nigeria Drug Repurposing Market Revenues & Volume Share, By Approach, 2021 & 2031F |
3.6 Nigeria Drug Repurposing Market Revenues & Volume Share, By Disease Area, 2021 & 2031F |
3.7 Nigeria Drug Repurposing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Nigeria Drug Repurposing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Nigeria Drug Repurposing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Nigeria Drug Repurposing Market Trends |
6 Nigeria Drug Repurposing Market, By Types |
6.1 Nigeria Drug Repurposing Market, By Approach |
6.1.1 Overview and Analysis |
6.1.2 Nigeria Drug Repurposing Market Revenues & Volume, By Approach, 2021 - 2031F |
6.1.3 Nigeria Drug Repurposing Market Revenues & Volume, By On-Target Repurposing, 2021 - 2031F |
6.1.4 Nigeria Drug Repurposing Market Revenues & Volume, By Off-Target Repurposing, 2021 - 2031F |
6.1.5 Nigeria Drug Repurposing Market Revenues & Volume, By Combination Drug Repurposing, 2021 - 2031F |
6.1.6 Nigeria Drug Repurposing Market Revenues & Volume, By Pathway-Based Repurposing, 2021 - 2031F |
6.2 Nigeria Drug Repurposing Market, By Disease Area |
6.2.1 Overview and Analysis |
6.2.2 Nigeria Drug Repurposing Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.2.3 Nigeria Drug Repurposing Market Revenues & Volume, By Neurodegenerative Diseases, 2021 - 2031F |
6.2.4 Nigeria Drug Repurposing Market Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031F |
6.2.5 Nigeria Drug Repurposing Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F |
6.3 Nigeria Drug Repurposing Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Nigeria Drug Repurposing Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.3 Nigeria Drug Repurposing Market Revenues & Volume, By Biotechnology Firms, 2021 - 2031F |
6.3.4 Nigeria Drug Repurposing Market Revenues & Volume, By Academic Research Institutes, 2021 - 2031F |
6.3.5 Nigeria Drug Repurposing Market Revenues & Volume, By Contract Research Organizations (CROs), 2021 - 2031F |
6.4 Nigeria Drug Repurposing Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 Nigeria Drug Repurposing Market Revenues & Volume, By Computational Drug Repurposing, 2021 - 2031F |
6.4.3 Nigeria Drug Repurposing Market Revenues & Volume, By High-Throughput Screening, 2021 - 2031F |
6.4.4 Nigeria Drug Repurposing Market Revenues & Volume, By Biomarker-Based Repurposing, 2021 - 2031F |
6.4.5 Nigeria Drug Repurposing Market Revenues & Volume, By AI & Machine Learning in Drug Repurposing, 2021 - 2031F |
7 Nigeria Drug Repurposing Market Import-Export Trade Statistics |
7.1 Nigeria Drug Repurposing Market Export to Major Countries |
7.2 Nigeria Drug Repurposing Market Imports from Major Countries |
8 Nigeria Drug Repurposing Market Key Performance Indicators |
9 Nigeria Drug Repurposing Market - Opportunity Assessment |
9.1 Nigeria Drug Repurposing Market Opportunity Assessment, By Approach, 2021 & 2031F |
9.2 Nigeria Drug Repurposing Market Opportunity Assessment, By Disease Area, 2021 & 2031F |
9.3 Nigeria Drug Repurposing Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Nigeria Drug Repurposing Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Nigeria Drug Repurposing Market - Competitive Landscape |
10.1 Nigeria Drug Repurposing Market Revenue Share, By Companies, 2024 |
10.2 Nigeria Drug Repurposing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here